| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,688 |
4,322 |
$440K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,455 |
3,205 |
$227K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
504 |
501 |
$67K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
244 |
244 |
$24K |
| 99442 |
|
243 |
233 |
$23K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
544 |
443 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
608 |
438 |
$11K |
| 99422 |
|
97 |
97 |
$6K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
55 |
52 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
274 |
235 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
87 |
83 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
612 |
604 |
$3K |
| 0012A |
|
49 |
49 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
19 |
$1K |
| 90756 |
|
42 |
41 |
$1K |
| 0011A |
|
35 |
35 |
$994.70 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
42 |
41 |
$828.15 |
| 99453 |
|
37 |
37 |
$125.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
26 |
$51.58 |
| 91301 |
|
104 |
103 |
$0.64 |